The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.
Carmistin The Food Company has secured financing of approximately €500 million to continue investments in agriculture and the food industry through a partnership with a bank syndicate.
Romanian construction company Bog'Art has published its 2024 Sustainability Report, marking the second year the company voluntarily reports on its ESG performance.
Fitch Ratings has affirmed its Long-Term Issuer Default Rating of BBB- with a negative outlook for Romanian state-owned nuclear power company Nuclearelectrica.
Nyerges & Partners advised Jinko Power Technology on its entry into the Romanian market through the acquisition of a 50 MW photovoltaic plant combined with a 150 MWh battery energy storage system (BESS) in Olt, southern Romania.
Griffes has leased 6,000 sqm of office space in Unirii View, one of Bucharest's Class A office buildings. Of the total space leased, 2,000 sqm represents new tenants, while three existing tenants expanded their operations.